Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

93 papers

Active filtersClassification:Supporting

Showing 25-36 of total 93 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

The phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neuronal death in mice.

Lee JH; Jeong JH; Mun BR; Jang JK; Choi YM; Baek JH; Choi WS

2026PubMedSupporting evidence

Plasma p-Tau217 and SPECT-Based eZIS in Mild Cognitive Impairment: Concordance Analysis with Validation in an Amyloid PET Sub-Cohort.

Huang IL; Matsuda H; Pai YT; Pai MC

Jan 1, 2026Diagnostics (Basel, Switzerland)

2026PubMedSupporting evidence

A validated workflow for paired total and small RNA sequencing from low-input submandibular gland biopsy specimens in de novo Parkinson's disease patients.

Choi KE; Kim JS

Jan 1, 2026Frontiers in aging neuroscience

2026PubMedSupporting evidence

EA-DualGAT: An error-aware dual-graph attention framework for Parkinson's disease diagnosis from wearable plantar pressure gait signals.

Rashnu A; Salimi-Badr A

Jan 1, 2026Computers in biology and medicine

2026PubMedSupporting evidence

A parsimonious three-gene mitochondrial classifier from frontal cortex for Alzheimer's disease: Nested cross-validation and multicenter external validation.

Wang M; Jing C; Wu T; Wang D

Jan 1, 2026Journal of Alzheimer's disease : JAD

2026PubMedSupporting evidence

Incidence of dementia and mild cognitive impairment in two Indigenous Bolivian cohorts.

Gatz M; Mack WJ; Eid Rodriguez D; Quispe Gutierrez R; Bani Cuata J; Chui HC; Walters EE; Cummings DK; Hooper PL; Zetterberg H; Finch CE; Trumble BC; Stieglitz J; Gurven MD; Thompson RC; Thomas GS; HORUS Team; Tsimane Health and Life History Project; Kaplan HS

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedSupporting evidence

Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden.

Mastrangelo A; Baiardi S; Ruggeri E; Bentivenga GM; Vargiu CM; Mammana A; Sbriccoli M; Polischi B; Carlà B; Capellari S; Parchi P

Jan 1, 2026Acta neuropathologica

2026PubMedSupporting evidence

Chronic kidney disease and cognitive decline: choroid plexus remodeling, glymphatic dysfunction, and alzheimer biomarker interpretation.

Corrêa LMA; Oliveira da Silva R; Brandão LKV; Delmiro Silva YR; da Silva ÉVB; Tretow J; Gomes EDC; Fernandes CCS; Moreira GNCM; Zanella J

Jan 1, 2026Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

2026PubMedSupporting evidence

Stage-dependent associations of glial fibrillary acidic protein and chitinase-3-like protein 1 with white matter network integrity in Alzheimer's disease.

Li OY; Turnbull A; Vankee-Lin F

Jan 1, 2026Journal of Alzheimer's disease : JAD

2026PubMedSupporting evidence

Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease.

Byeon G; Lee JW; Kim S; Um YH; Wang SM; Ha S; Park SY; Shin I; Jang J; Lee CU; Lim HK; Kang DW

Jan 1, 2026Alzheimer's & dementia (New York, N. Y.)

2026PubMedSupporting evidence

Parkinson's disease diagnosis using machine learning and multimodal biomarkers: A systematic review.

Khan MI; Imran A; Alshammari A

Jan 1, 2026Computational biology and chemistry

2026PubMedSupporting evidence

Hippocampal mediation in the lipid-Alzheimer's disease pathway: A high-dimensional mediation analysis stratified by APOE and sex.

Cao Y; Fan Y; Meng Q; Wang J; Chen R; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Metabolomics Consortium

Jan 1, 2026Alzheimer's & dementia (New York, N. Y.)